Singapore Medical Group to delist from SGX-ST

It will delist on 20 January.

Singapore Medical Group (SMG) will delist from the Catalist board of the SGX-ST on 20 January at 9 a.m.

The delisting announcement came after its privatisation last month.

In December 2022, TLW Success received 95.14 per cent of valid acceptances for its offer to acquire all the issued and paid-up ordinary shares in SMG.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia